Serum S100B correlates with health-related quality of life and functional outcome in patients at 1 year after aneurysmal subarachnoid haemorrhage

BACKGROUND: Early, objective prognostication after aneurysmal subarachnoid haemorrhage (aSAH) is difficult. A biochemical marker would be desirable. Correlation has been found between levels of the protein S100 beta (S100B) and outcome after aSAH. Timing and clinical usefulness are under investigati...

Descripción completa

Detalles Bibliográficos
Autores principales: Aineskog, Helena, Johansson, Conny, Nilsson, Robert, Koskinen, Lars-Owe D., Lindvall, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Original Article - Vascular Neurosurgery - Aneurysm
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338103/
https://www.ncbi.nlm.nih.gov/pubmed/35748928
http://dx.doi.org/10.1007/s00701-022-05272-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338103/
https://www.ncbi.nlm.nih.gov/pubmed/35748928
http://dx.doi.org/10.1007/s00701-022-05272-0

Ejemplares similares